Ernexa Therapeutics reports complete tumor elimination in ovarian cancer study

Go back to Ernexa Therapeutics reports complete tumor elimination in ovarian cancer study
(NASDAQ: ERNA) Delayed: 4.02 -0.43 (9.66%)
Previous Close $4.45    52 Week High
Open $4.33    52 Week Low
Day High $4.46    P/E N/A 
Day Low $3.98    EPS
Volume 60,272